Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(67%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Relationship Between Gut Microbiome, Probiotics, and Mild Cognitive Impairment

NCT04971096
terminatednot_applicable

Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome

NCT05813899
completednot_applicable

Psychiatric Symptoms in Employees Experiencing High Levels of Stress Before and After the Intake of Probiotics

NCT04452253

Clinical Trials (3)

Showing 3 of 3 trials
NCT04971096Not Applicable

Relationship Between Gut Microbiome, Probiotics, and Mild Cognitive Impairment

Terminated
NCT05813899Not Applicable

Efficacy of Lactobacillus Paracasei PS23 for Patients With Post-COVID-19 Syndrome

Terminated
NCT04452253Not Applicable

Psychiatric Symptoms in Employees Experiencing High Levels of Stress Before and After the Intake of Probiotics

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3